Memantina Viatris

Memantine Hydrochloride, the active ingredient in Memantina Viatris, is a NMDA receptor antagonist presented as an oral formulation for oral use. It is indicated for the treatment of moderate to severe Alzheimer’s disease in adults.

GNH USA supplies Memantina Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantina Viatris is a NMDA‑receptor antagonist used in the management of neurodegenerative disease. - Moderate to severe Alzheimer’s disease: helps maintain cognitive function and daily living abilities in patients with established disease.

Memantina Viatris may be associated with a range of adverse reactions.

Common Side Effects: - Dizziness - Headache - Constipation - Confusion - Fatigue - Hypertension

Serious or Rare Side Effects: - Seizures - Cardiac arrhythmia - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe hepatic dysfunction - Persistent hallucinations

Before prescribing Memantina Viatris, clinicians should consider several safety factors. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Hepatic impairment: monitor liver enzymes and consider dose reduction. - History of seizures: use with caution as the drug can lower seizure threshold. - Elderly patients: increased risk of confusion and falls; monitor closely. - Concomitant NMDA antagonists: avoid combined use due to additive neuro‑psychiatric effects. - Store below 25°C: keep in the original pack, protect from moisture.

Memantina Viatris can interact with other medicines that affect the central nervous system or cardiac function.

Major Interactions (Avoid): - Other NMDA‑receptor antagonists (e.g., amantadine, dextromethorphan): may increase neuro‑psychiatric toxicity. - High‑dose anticholinergic agents: can exacerbate confusion and cognitive decline.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, opioids): may enhance sedation. - Antihypertensive drugs: possible additive blood‑pressure lowering effect. - Diuretics: monitor electrolyte balance and renal function. - Antiepileptic drugs: may alter seizure threshold.